Status:
UNKNOWN
Effect of N-acetylcysteine as Add on Therapy With SSRI in Moderate to Severe OCD Patients
Lead Sponsor:
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Conditions:
OCD
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Title: Effect of n-acetylcysteine as add-on therapy with Selective Serotonin Reuptake Inhibitors in moderate to severe Obsessive Compulsive Disorder patients. Purpose of the study: To assess the ef...
Detailed Description
Obsessive-compulsive disorder (OCD) is the fourth most common mental disorder in Bangladesh and around the world. Selective serotonin reuptake inhibitors (SSRIs) are commonly administered drugs for tr...
Eligibility Criteria
Inclusion
- Newly diagnosed OCD patients diagnosed by Psychiatric Consultant of the Department of Psychiatry according to DSM-5 criteria (Appendix VI).
- Moderate to severe OCD patients having AY-BOCS score \> 16
- Age: 18 years or above
- Sex: Both male and female
Exclusion
- Patients receiving antidepressant within last two months.
- Patients having any history of psychiatric and medical conditions will be excluded from the study.
- Patients having suicidal thoughts.
- Pregnancy and lactation.
- Patients who are receiving psychotherapy.
Key Trial Info
Start Date :
March 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 10 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04904952
Start Date
March 13 2020
End Date
January 10 2022
Last Update
November 16 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
BSMMU
Dhaka, Bangladesh, 1000
2
Sadia Binte Anwar Sonia
Dhaka, Bangladesh, 1000